ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 68 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,650 | -8.5% | 1,094,500 | -43.5% | 0.00% | 0.0% |
| Q2 2023 | $2,032,669 | +110914.1% | 1,935,875 | +26.8% | 0.00% | 0.0% |
| Q1 2023 | $1,831 | +0.8% | 1,526,159 | +26.0% | 0.00% | 0.0% |
| Q4 2022 | $1,817 | -99.9% | 1,211,099 | +143.8% | 0.00% | 0.0% |
| Q3 2022 | $1,555,000 | +396.8% | 496,697 | +420.1% | 0.00% | – |
| Q2 2022 | $313,000 | -58.0% | 95,499 | -7.1% | 0.00% | – |
| Q4 2021 | $746,000 | +165.5% | 102,781 | +1447.7% | 0.00% | – |
| Q3 2021 | $281,000 | – | 6,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $9,710,663 | 12.83% |
| Alphabet Inc. | 5,680,785 | $5,964,824 | 0.32% |
| 683 Capital Management, LLC | 4,000,000 | $4,200,000 | 0.30% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,034,067 | 0.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,151,843 | $1,209,435 | 0.18% |
| Slate Path Capital LP | 3,735,000 | $3,921,750 | 0.14% |
| BML Capital Management, LLC | 134,696 | $141,431 | 0.13% |
| Orbimed Advisors | 5,270,400 | $5,533,920 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $1,512,761 | 0.06% |
| MAVERICK CAPITAL LTD | 2,338,373 | $2,455,292 | 0.05% |